Information
-
Trademark
-
77832375
-
Serial Number
77832375
-
Registration Number
4451588
-
International Classifications
-
Filing Date
September 22, 2009
15 years ago
-
Registration Date
December 17, 2013
11 years ago
-
Transaction Date
April 23, 2024
a year ago
-
Status Date
February 21, 2024
a year ago
-
Published for Opposition Date
August 30, 2011
13 years ago
-
Renewal Date
December 17, 2023
a year ago
-
Location Date
February 21, 2024
a year ago
-
First Use Anywhere Date
September 26, 2001
23 years ago
-
First Use In Commerce Date
September 26, 2001
23 years ago
-
Status Code
800
-
Current Location
GENERIC WEB UPDATE
Employee Name
JUN, WON KYUNG WENDY
-
Attorney Docket Number
120776LCL003
Attorney Name
Mainak H. Mehta
Law Office Assigned Location Code
L30
-
Owners
Mark Drawing Code
4
Mark Identification
SERACARE
Case File Statements
- GS0051: Diagnostic reagents for medical and veterinary use; Clinical medical reagents; Diagnostic chemicals, reagents or preparations for medical and veterinary use; Chemical reagents for medical and veterinary use; Chemical reagents for pharmaceutical purposes and use in the pharmaceutical industry, namely, chemical reagents for use as diluents and excipients; Testing reagents for medical or clinical use; Genetic testing controls for the testing of human serum, infectious disease antibodies and antigens, and viral nucleic acids, namely, medical diagnostic reagents and assays; Chemical reference materials, namely, quality controls and panels in the nature of human compounds for medical or veterinary use; Chemical reference specimens, namely, serological, viral, genetic and nucleic acid reference specimens in the nature of human serum, infectious disease antibodies and antigens for medical or veterinary use
- PM0000: SERA CARE
- CC0000: Color is not claimed as a feature of the mark.
- TR0010: The wording "SERA" has no meaning in a foreign language.
- GS0011: Diagnostic chemicals, reagents or preparations for scientific, research or manufacturing use in chemical, pharmaceutical and biotechnology industries; Diagnostic reagents for clinical, medical laboratory or manufacturing use in chemical, pharmaceutical and biotechnology industries; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry, microbiology; Reagents and tools, namely, animal serums, bovine serum albumin, and human blood products, namely, plasma, serum, cells, and human serum albumin, and chromogenic substrates, all for research purposes or manufacturing use in chemical, pharmaceutical and biotechnology industries; Chemical reagents other than for medical or veterinary purposes; Chemical preparations for scientific purposes; Chemical ingredients for use as exipients or diluents in the manufacture of pharmaceuticals; Chemical reagents for reference control, namely, genetic testing controls and controls for the testing of human serum, infectious disease antibodies and antigens, and viral nucleic acids, all for industrial use and not for medical purposes; Chemical solutions in the nature of quality control standard solutions for testing human serum, infectious disease antibodies and antigens, human genetics, and viral nucleic acids, all for industrial use and not for medical purposes; Chemical control serum for scientific or research use in the nature of quality controls for infectious disease and genetic testing; Biochemical control serum for scientific or research use in the nature of quality controls for infectious disease and genetic testing; Biochemical standard serum for scientific or research use; Quality control standard solutions and quality control materials for testing and calibrating medical apparatus and reagents for scientific and research purposes and for clinical or medical laboratory use; Standard serum, control serum, biochemical standard serum, biochemical control serum for scientific and research purposes and for clinical or medical laboratory use
- GS0421: Custom design and development of chemical reagents and biochemical assays; Providing reagent sample testing for others in the fields of, science and research related thereto; Research support services in the nature of assay development and validation, product development, and report generation, all in the fields of virology, immunological, biological and biochemical research
Case File Event Statements
-
12/19/2009 - 15 years ago
7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
9/25/2009 - 15 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
9/25/2009 - 15 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
9/26/2009 - 15 years ago
3 - NOTICE OF PSEUDO MARK MAILED
Type: MPMK
-
12/18/2009 - 15 years ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
12/19/2009 - 15 years ago
5 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
12/19/2009 - 15 years ago
6 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
7/29/2010 - 14 years ago
17 - NOTIFICATION OF FINAL REFUSAL EMAILED
Type: GNFN
-
12/19/2009 - 15 years ago
8 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
12/19/2009 - 15 years ago
9 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
12/19/2009 - 15 years ago
10 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
6/21/2010 - 14 years ago
11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
7/9/2010 - 14 years ago
12 - ASSIGNED TO LIE
Type: ALIE
-
7/9/2010 - 14 years ago
13 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
7/9/2010 - 14 years ago
14 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
7/29/2010 - 14 years ago
15 - FINAL REFUSAL WRITTEN
Type: CNFR
-
7/29/2010 - 14 years ago
16 - FINAL REFUSAL E-MAILED
Type: GNFR
-
2/17/2011 - 14 years ago
27 - LAW OFFICE PUBLICATION REVIEW COMPLETED
Type: PREV
-
10/13/2010 - 14 years ago
18 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
1/31/2011 - 14 years ago
19 - EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Type: CPEA
-
1/31/2011 - 14 years ago
20 - EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Type: GEAP
-
1/31/2011 - 14 years ago
21 - NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Type: GEAN
-
2/1/2011 - 14 years ago
22 - COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Type: CEPE
-
2/1/2011 - 14 years ago
23 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
2/3/2011 - 14 years ago
24 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
2/3/2011 - 14 years ago
25 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
2/17/2011 - 14 years ago
26 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
7/20/2011 - 13 years ago
37 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
2/28/2011 - 14 years ago
28 - WITHDRAWN FROM PUB - OG REVIEW QUERY
Type: PBCR
-
3/15/2011 - 14 years ago
29 - PREVIOUS ALLOWANCE COUNT WITHDRAWN
Type: ZZZX
-
3/23/2011 - 14 years ago
30 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
3/23/2011 - 14 years ago
31 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
3/23/2011 - 14 years ago
32 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
7/18/2011 - 13 years ago
33 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
7/18/2011 - 13 years ago
34 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
7/18/2011 - 13 years ago
35 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
7/19/2011 - 13 years ago
36 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
10/25/2012 - 12 years ago
47 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
7/26/2011 - 13 years ago
38 - LAW OFFICE PUBLICATION REVIEW COMPLETED
Type: PREV
-
8/30/2011 - 13 years ago
39 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
8/30/2011 - 13 years ago
40 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
10/25/2011 - 13 years ago
41 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM
-
4/25/2012 - 13 years ago
42 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
4/25/2012 - 13 years ago
44 - SOU EXTENSION 1 FILED
Type: EXT1
-
5/16/2012 - 12 years ago
45 - SOU EXTENSION 1 GRANTED
Type: EX1G
-
5/16/2012 - 12 years ago
43 - CASE ASSIGNED TO INTENT TO USE PARALEGAL
Type: AITU
-
5/17/2012 - 12 years ago
46 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
11/6/2013 - 11 years ago
57 - STATEMENT OF USE PROCESSING COMPLETE
Type: SUPC
-
10/25/2012 - 12 years ago
48 - SOU EXTENSION 2 FILED
Type: EXT2
-
10/30/2012 - 12 years ago
49 - SOU EXTENSION 2 GRANTED
Type: EX2G
-
10/31/2012 - 12 years ago
50 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
4/25/2013 - 12 years ago
51 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
4/25/2013 - 12 years ago
52 - SOU EXTENSION 3 FILED
Type: EXT3
-
5/1/2013 - 11 years ago
53 - SOU EXTENSION 3 GRANTED
Type: EX3G
-
5/2/2013 - 11 years ago
54 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
10/24/2013 - 11 years ago
55 - TEAS STATEMENT OF USE RECEIVED
Type: EISU
-
10/24/2013 - 11 years ago
56 - USE AMENDMENT FILED
Type: IUAF
-
11/12/2013 - 11 years ago
59 - LAW OFFICE REGISTRATION REVIEW COMPLETED
Type: REGV
-
12/17/2018 - 6 years ago
62 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Type: REM1
-
11/11/2013 - 11 years ago
58 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Type: CNPR
-
11/13/2013 - 11 years ago
60 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Type: SUNA
-
12/17/2013 - 11 years ago
61 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
6/12/2020 - 4 years ago
63 - TEAS SECTION 8 & 15 RECEIVED
Type: E815
-
8/10/2020 - 4 years ago
65 - REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Type: C15A
-
8/10/2020 - 4 years ago
64 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Type: APRE
-
8/10/2020 - 4 years ago
66 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Type: NA85
-
10/5/2022 - 2 years ago
67 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Type: ASGN
-
12/17/2022 - 2 years ago
68 - COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Type: REM2
-
8/26/2023 - a year ago
69 - TEAS SECTION 8 & 9 RECEIVED
Type: E89R
-
2/21/2024 - a year ago
71 - REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Type: 89AG
-
2/21/2024 - a year ago
72 - REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Type: RNL1
-
2/21/2024 - a year ago
70 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Type: APRE
-
2/21/2024 - a year ago
73 - NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Type: NA89